| Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial Presenter: Jonathan P. Piccini, Duke Clinical Research Institute, Duke University Medical Center, Durham, N.C.
|
Moderators:
| Panelists:
|
